[1] Daghem M, Bing R, Fayad ZA, et al. Noninvasive imaging to assess atherosclerotic plaque composition and disease activity: coronary and carotid applications[J]. JACC Cardiovasc Imaging, 2020, 13(4): 1055-1068.
[2] 李彤, 徐晨曦, 王钰碧, 等. 血浆致动脉硬化指数对冠心病合并2型糖尿病病人冠状动脉病变程度的预测价值[J]. 中西医结合心脑血管病杂志, 2023, 21(24): 4496-4500.
[3] 邱丽浈, 邱友燕, 陈晓珠. 2型糖尿病患者心脏自主神经病变发生情况及其危险因素[J]. 慢性病学杂志, 2022, 23(8): 1139-1141.
[4] 冯飞, 虞萌, 蓝雅琳. 老年2型糖尿病患者继发心脏自主神经病变影响因素[J]. 中国老年学杂志, 2022, 42(18): 4412-4415.
[5] Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23): 6212-6222.
[6] Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease[J]. Coron Artery Dis, 2021, 32(8): 715-720.
[7] Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J]. Metab Syndr Relat Disord, 2008, 6(4): 299-304.
[8] Khan SH, Sobia F, Niazi NK, et al. Metabolicclustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance[J]. Diabetol Metab Syndr, 2018, 10: 74.
[9] Zhao J, Fan H, Wang T, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients[J]. Cardiovasc Diabetol, 2022, 21(1): 123.
[10] Saraste A, Knuuti J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: recommendations for cardiovascular imaging[J]. Herz, 2020, 45(5): 409-420.
[11] 中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志, 2021, 41(9): 757-784.
[12] Rampidis GP, Benetos G, Benz DC, et al. A guide for gensini score calculation[J]. Atherosclerosis, 2019, 287: 181-183.
[13] 马小利, 张芳芳. 2022年美国心脏病学会年会会议纪要: 与糖尿病相关的心血管疾病学术进展[J]. 中华内分泌代谢杂志, 2023, 39(3): 273-277.
[14] Wang C, Li F, Guo J, et al. Insulin resistance, blood glucose and inflammatory cytokine levels are risk factors for cardiovascular events in diabetic patients complicated with coronary heart disease[J]. Exp Ther Med, 2018, 15(2): 1515-1519.
[15] Lee EY, Yang HK, Lee J, et al. Triglyceride glucose index, a marker of insulin resistance, is ass- ociated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes[J]. Lipids Health Dis, 2016, 15(1): 155.
[16] Emamalipour M, Seidi K, Jahanban-Esfahlan A, et al. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: impairing insulin function and inducing pro-inflammatory cytokines[J]. J Cell Physiol, 2019, 234(12): 21758-21769.
[17] Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification[J]. Diabetes Care, 2019, 42(8): 1569-1573.
[18] Zhao S, Yu S, Chi C, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai study[J]. Cardiovasc Diabetol, 2019, 18(1): 95.
[19] Thai PV, Tien HA, van Minh H, et al. Triglyceride glucose index for the detection of asympt- omatic coronary artery stenosis in patients with type 2 diabetes[J]. Cardiovasc Diabetol, 2020, 19(1): 137.
[20] Mao Q, Zhou D, Li Y, et al. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with Non-ST-segment elevation acute coronary syndrome[J]. Dis Markers, 2019, 2019: 6891537.
[21] 廖丽萍, 周跟东, 张晓红, 等. 甘油三酯葡萄糖乘积指数对中青年人群冠心病及冠状动脉狭窄程度的预测价值[J]. 中国心血管病研究, 2021, 19(5): 440-444.
[22] Jin JL, Sun D, Cao YX, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study[J]. Ann Med, 2018, 50(7): 576-586.
[23] 孙梓宜, 王子涵, 陈颖, 等. TyG指数联合血管功能指标对冠状动脉狭窄程度的预测价值[J]. 临床心血管病杂志, 2022, 38(1): 17-21.
[24] Tsiantoulas D, Diehl CJ, Witztum JL, et al. B cells and humoral immunity in atherosclerosis[J]. Circ Res, 2014, 114(11): 1743-1756.
[25] Fernández-Ruiz I. Neutrophil-driven SMC death destabilizes atherosclerotic plaques[J]. Nat Rev Cardiol, 2019, 16(8): 455.
[26] Mulholland M, Jakobsson G, Lei Y, et al. IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice[J]. Atherosclerosis, 2021, 326: 1-10.
[27] Núñez J, Miñana G, Bodí V, et al. Low lymphocyte count and cardiovascular diseases[J]. Curr Med Chem, 2011, 18(21): 3226-3233.
[28] Soria-Florido MT, Schröder H, Grau M, et al. High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis[J]. Atherosclerosis, 2020, 302: 36-42.
[29] Açar G, Fidan S, Uslu ZA, et al. Relationship of neutrophil-lymphocyte ratio with thepresence, severity, and extent of coronary atherosclerosis detected by coronary computed tomography angiography[J]. Angiology, 2015, 66(2): 174-179.
[30] Uysal HB, Dalğ B, Akgüllü C, et al. Blood count parameters can predict the severity of coronary artery disease[J]. Korean J Intern Med, 2016, 31(6): 1093-1100.
[31] Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity[J]. Anatol J Cardiol, 2015, 15(8): 640-647.
[32] Fest J, Ruiter R, Ikram MA, et al. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study[J]. Sci Rep, 2018, 8(1): 10566.
[33] Candemir M, Kiziltunç E, Nurkoç S, et al. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease[J]. Angiology, 2021, 72(6): 575-581.
[34] Huang J, Zhang Q, Wang R, et al. Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention[J]. Med Sci Monit, 2019, 25: 9690-9701.
[35] Xu M, Chen R, Liu L, et al. Systemic immune-inflammation index and incident cardio- vascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study[J]. Atherosclerosis, 2021, 323: 20-29.
[36] Montezano AC, Dulak-Lis M, Tsiropoulou S, et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies[J]. Can J Cardiol, 2015, 31(5): 631-641.